FlexifyMe Secures INR 10 Crore in Seed Funding Round Led by IvyCap Ventures and Flipkart Ventures

• ByStartupStory     |    January 11, 2024

FlexifyMe, a pioneering Chronic Pain Management Platform, has successfully closed its Seed funding round, raising INR 10 Crore from leading investors IvyCap Ventures and Flipkart Ventures. The funding round also saw active participation from esteemed investors GSF, Chandigarh Angels, Venture Catalyst, and Ah Ventures.

The company has outlined strategic plans to utilize these funds to revolutionize chronic pain management by integrating cutting-edge technology and progressive exercises. The primary focus is to provide long-lasting relief and elevate workplace wellness to new heights.

According to a statement, global chronic pain affecting over 2 billion people is exacerbated by sedentary lifestyles and postural misalignments.

FlexifyMe, as India’s leading chronic pain management solution, aims to deploy the funds to strengthen its technology and introduce progressive exercises. The company’s overarching objective is to help corporates understand ergonomic challenges, eliminate postural misalignments, enhance employee productivity, and ensure continuous health monitoring. This is expected to contribute to stress alleviation and an overall improvement in lifestyle disorders.

Established in October 2021 by seasoned entrepreneurs Manjeet Singh and Amit Bhayani, FlexifyMe is committed to redefining conventional physiotherapy through its groundbreaking AI motion-tracking technology.

Commenting on the investment, Vikram Gupta, Founder and Managing Partner, said, “FlexifyMe’s innovative approach convinced us of its potential to revolutionize healthcare. We believe in the power of FlexifyMe’s unique platform, backed by its dedicated team, to transform the lives of millions suffering from chronic pain. The ambitious goals set by the founders align seamlessly with our vision for impactful investments.”

Co-Founders Manjeet Singh and Amit Bhayani expressed their gratitude for the investment round and the trust bestowed by their investors in their vision. They emphasized their commitment to harnessing advanced technology in healthcare to aid one million individuals in finding relief from chronic pain by 2027.

Follow Startup Story